NeuMoDx Molecular Revenue and Competitors

Claim your profile

Detroit, MI USA

Location

$66M

Total Funding

Estimated Revenue & Valuation

  • NeuMoDx Molecular's estimated annual revenue is currently $22.1M per year.(i)
  • NeuMoDx Molecular received $20.0M in venture funding in May 2016.
  • 0
  • NeuMoDx Molecular's total funding is $66M.

Employee Data

    00
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M4N/AN/AN/A
#2
$43.2M172-9%N/AN/A
#3
$7M28-10%N/AN/A
#4
$214.6M8550%N/AN/A
#5
$6.5M260%N/AN/A
#6
$11.5M460%N/AN/A
#7
$4M16N/AN/AN/A
#8
$4.3M17-37%N/AN/A
#9
$25.4M101-9%N/AN/A
#10
$22.1M0N/A$66MN/A

keywords:B2B

$66M

Total Funding

N/A

Number of Employees

$22.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

NeuMoDx Molecular News

2014-04-01 - NeuMoDx Molecular Raises $21M in Series B Financing

NeuMoDx Molecular, Inc., an Ann Arbor, MI-based diagnostics company developing a new platform for high throughput, low cost molecular testing, raised $21m in Series B financing. The round was led by Pfizer Ventures with participation from Baird Capital, Venture Investors and existing investors ...

2014-04-01 - Baird Capital Co-Leads $21 Million Series B Financing for NeuMoDx Molecular Inc.

Baird Capital co-led a $21 million Series B financing in NeuMoDx Molecular Inc., a diagnostics company developing a new platform for high-efficiency, low-cost molecular testing. “Molecular diagnostic testing continues to be an attractive investment area for us and we look forward to working with ...

2019-06-20 - BD sues NeuMoDx over patents for diagnostic device

Becton Dickinson (NYSE:BDX) and subsidiaries HandyLab and GeneOhm Sciences Canada have filed a lawsuit against diagnostics company NeuMoDx, claiming patent infringement. BD acquired small diagnostics company HandyLab (Ann Arbor, Mich.) in 2009 for $275 million. HandyLab was developing bench-top ...

08/12/2019 - NeuMoDx Files Defense, Counterclaims in BD Patent ...

NEW YORK – NeuMoDx has filed a response with the District of ... by Becton Dickinson that the molecular diagnostics developer infringed on ...

09/05/2019 - Global Biochips Market Overview 2019: Market Value ...

1.1.8.2.1.1 Lab-on-a-chip and Molecular Biology ... Cancer Therapy; QIAGEN NV Selects NeuMoDx Molecular, Inc for CE-IVD Assays Purchase ...

04/11/2019 - QIAGEN and NeuMoDx expand assay menu for their next ...

BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced an expansion ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M0N/A$31.2M
#2
$133.4M0N/A$1.4M
#3
$6.2M0N/A$427M
#4
$7.6M0N/A$12.4M
#5
$212.7M0N/A$13.4M

NeuMoDx Molecular Funding

DateAmountRoundLead InvestorsReference
2014-03-28$10.5MUndisclosedArticle
2014-04-02$21.0MBPfizer VenturesArticle
2016-05-03$20.0MUndisclosedArticle